William Larkins
Corporate Officer/Principal bei HIKMA PHARMACEUTICALS PLC
Aktive Positionen von William Larkins
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HIKMA PHARMACEUTICALS PLC | Corporate Officer/Principal | 01.01.2022 | - |
Karriereverlauf von William Larkins
Ehemalige bekannte Positionen von William Larkins
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CUSTOpharm, Inc.
CUSTOpharm, Inc. Pharmaceuticals: MajorHealth Technology CUSTOpharm, Inc. provides personalized chemistry and regulatory support services. It provides personalized cost-effective chemistry and manufacturing controls (CMC) and regulatory support to companies with limited resources and those seeking to expand into new areas. The firm offers product development services that focus on non-clinical, clinical, marketing, and other aspects of drug development and distribution; sourcing of product manufacturing with specialization in injectable dosage forms, including suspensions, lyophilized, and cytotoxic compounds, technology transfer, regulatory support, such as electronic submissions, electronic hybrids, paper applications/CTD/traditional format, structured product labeling. The company was founded by David McCleary in 2005 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | - | 01.09.2022 |
Vorstandsvorsitzender | 03.02.2015 | 01.09.2022 |
Ausbildung von William Larkins
The Ohio State University | Doctorate Degree |
Purdue University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
HIKMA PHARMACEUTICALS PLC | Health Technology |
Private Unternehmen | 1 |
---|---|
CUSTOpharm, Inc.
CUSTOpharm, Inc. Pharmaceuticals: MajorHealth Technology CUSTOpharm, Inc. provides personalized chemistry and regulatory support services. It provides personalized cost-effective chemistry and manufacturing controls (CMC) and regulatory support to companies with limited resources and those seeking to expand into new areas. The firm offers product development services that focus on non-clinical, clinical, marketing, and other aspects of drug development and distribution; sourcing of product manufacturing with specialization in injectable dosage forms, including suspensions, lyophilized, and cytotoxic compounds, technology transfer, regulatory support, such as electronic submissions, electronic hybrids, paper applications/CTD/traditional format, structured product labeling. The company was founded by David McCleary in 2005 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- William Larkins
- Erfahrung